VEGF(165) promotes the osteolytic bone destruction of Ewing's sarcoma tumors by upregulating RANKL

The purpose of this study was to determine whether vascular endothelial growth factor-165 (VEGF(165)) contributed to the osteolytic process in Ewing's sarcoma. VEGF(165) induced osteoclast formation from murine bone marrow cells. Tartrate-resistant acid phosphatase (TRAP) staining demonstrated...

Full description

Saved in:
Bibliographic Details
Main Authors: Guan, Hui, Zhou, Zhichao, Cao, Ying, Duan, Xiaoping, Kleinerman, Eugenie S.
Format: Artigo
Language:Inglês
Published: 2009
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875875/
https://ncbi.nlm.nih.gov/pubmed/20066901
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items